Possibilities for the prediction of disease progression after radical surgical treatment of gastric cancer
Abstract
It has been provided a method for predicting of disease progression after radical surgical treatment of gastric cancer, that includes evaluation of the methylation status of RECK gene primary tumor and in the peritoneal washings after lymph node dissection in combination with the assessment of the degree of metastatic involvement of regional lymph nodes.
About the Authors
M. Yu. Reutovich
РНПЦ ОМР им. Н. Н. Александрова
Belarus
Belarus
A. I. Shmak
РНПЦ ОМР им. Н. Н. Александрова
Belarus
Belarus
References
1. Patient survival after D1 and D2 resection for gastric cancer: long-term results of the MRC randomized surgical trial. Surgical Co-operative group / A. Cuschieri [et al.] // Brit. J. Cancer. – 1999. – Vol. 79, № 9–10. – P. 1522–1530.
2. Современное состояние проблемы комбинированного лечения местнораспространенного рака желудка: основные тенденции клинической онкологии / М. Д. ТерОванесов [и др.] // Вопр. онкологии. – 2015. – Т. 61, № 3. – С. 329–338.
3. European Society for Medical Oncology (ESMO); European Society for Surgical Oncology (ESSO); European Society of Radiotherapy and Oncology (ESTRO). Gastric Cancer: ESMO- ESSO- ESTRO clinical practice giudelines for diagnosis, treatment and follow-up / T. Waddell [et al.] // Eur. J. Surg. Oncol. – 2014. – Vol. 40. – P. 584–591.
4. Скоропад, В. Ю. Современное состояние адъювантной терапии рака желудка после радикальных оперативных вмешательств с расширенной лимфодиссекцией / В. Ю. Скоропад // Вопр. онкологии. – 2015. – Т. 61, № 3. – С. 339–345.
5. Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer / D. Cunningham [et al.] // N. Engl. J. Med. – 2006. – Vol. 350. – P. 11–20.
6. Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction / J. S. MacDonald [et al.] // N. Engl. J. Med. – 2001. – Vol. 345. – P. 725–730.
7. Ushijima, T., Sasako M. Focus on gastric cancer / T. Ushijima, M. Sasako // Cancer Cell. – 2004. – Vol. 5. – P. 121–125.
8. Global estimates of cancer prevalence for 27 sites in the adult population in 2008 / F. Bray [et al.] // Int. J. Cancer. – 2013. – Vol. 132. – P. 1133–1145.
9. Integrin aJeon, CH, Shin IH, Park JB, et al. Prognostic significance of MAGE in peritoneal washes in gastric carcinoma patients without peritoneal metastasis results of a 5-year follow-up study / C. H. Jeon [et al.] // J. Clin. Gastroenterol. – 2010. – Vol. 44. – P. 682–686.
10. Reim, D. Prognostic implications of the seventh edition of the international union against cancer classification for patients with gastric cancer: the Western experience of patients treated in a single-center European institution / D. Reim, M. Loos, F. Vogl // J. Clin. Oncol. – 2013. – Vol. 10 – N. 31 – P. 263-271.
Review
For citations:
Reutovich M.Yu., Shmak A.I. Possibilities for the prediction of disease progression after radical surgical treatment of gastric cancer. Military Medicine. 2017;(3):93-99. (In Russ.)
Views:
69
JATS XML
Email this article 